Cabinet Barny advised Kaldi Pharma, a subsidiary company of Domain Therapeutics, on the grant from Kaldi Pharma to Clevexel of a license to develop a potential preclinical drug candidate in Parkinson’s disease.

Cabinet Barny advised GamaMabs Pharma on the conclusion of a collaboration agreement with Mayo Clinic on the study on the efficacy of one of GamaMabs Pharma’s monoclonal antibody in ovarian cancer.

Cabinet Barny advised Enterome on the conclusion of a collaborative research and development agreement with AbbVie in the field of the gut microbiome in Crohn’s disease.

Cabinet Barny advised Immutep on the acquisition of Immutep by Prima BioMed, funded via an investment agreement with Bergen Global Opportunity Fund.